HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio Bucolo Selected Research

Antipsychotic Agents (Antipsychotics)

1/2020Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
1/2017Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudio Bucolo Research Topics

Disease

30Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 11/2008
25Inflammation (Inflammations)
04/2021 - 02/2002
10Glaucoma
01/2022 - 04/2003
10Macular Degeneration (Age-Related Maculopathy)
01/2022 - 01/2015
8Ocular Hypertension (Glaucoma, Suspect)
11/2019 - 12/2002
7Retinal Diseases
01/2022 - 06/2007
6Dry Eye Syndromes (Dry Eye Syndrome)
01/2019 - 07/2009
5Macular Edema
01/2022 - 05/2015
5Ischemia
04/2021 - 09/2004
4Alzheimer Disease (Alzheimer's Disease)
10/2021 - 01/2015
4Wounds and Injuries (Trauma)
05/2021 - 07/2002
4Neurodegenerative Diseases (Neurodegenerative Disease)
04/2021 - 01/2015
4Hyperglycemia
10/2020 - 06/2015
4Uveitis
01/2017 - 03/2003
3Neuroinflammatory Diseases
01/2022 - 10/2013
3Neoplasms (Cancer)
11/2021 - 04/2019
3Optic Nerve Diseases (Optic Neuropathy)
09/2021 - 11/2013
3Hypoxia (Hypoxemia)
01/2020 - 12/2015
3Asthma (Bronchial Asthma)
01/2011 - 02/2008
3Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2011 - 03/2008
3Reperfusion Injury
11/2008 - 09/2004
2Rare Diseases (Rare Disease)
11/2021 - 01/2020
2Corneal Injuries
11/2020 - 01/2019
2Schizophrenia (Dementia Praecox)
01/2020 - 01/2017
2Cataract (Cataracts)
01/2020 - 10/2006
2Pain (Aches)
01/2020 - 01/2017
2Body Weight (Weight, Body)
01/2019 - 03/2011
2Depressive Disorder (Melancholia)
01/2014 - 01/2014
2Type 2 Diabetes Mellitus (MODY)
02/2013 - 01/2013
2Ocular Hypotension
03/2012 - 02/2010
2Miosis
03/2006 - 07/2002
1Gliosis
10/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
05/2021
1Choroidal Neovascularization
04/2021

Drug/Important Bio-Agent (IBA)

32Retinaldehyde (Retinal)IBA
01/2022 - 09/2004
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 12/2013
12Pharmaceutical PreparationsIBA
08/2021 - 07/2002
11Glucose (Dextrose)FDA LinkGeneric
05/2021 - 12/2013
8MicroRNAs (MicroRNA)IBA
10/2021 - 01/2015
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2015
6Streptozocin (Streptozotocin)FDA Link
02/2020 - 08/2009
5Proteins (Proteins, Gene)FDA Link
10/2021 - 09/2002
5Ophthalmic Solutions (Eye Drops)IBA
01/2019 - 02/2002
4Purinergic P2X7 ReceptorsIBA
01/2022 - 01/2017
4AntioxidantsIBA
04/2021 - 10/2013
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 03/2008
4afliberceptIBA
12/2020 - 01/2015
4LipopolysaccharidesIBA
11/2020 - 03/2003
4AtropineFDA LinkGeneric
01/2019 - 03/2011
4Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2019 - 09/2012
4EndotoxinsIBA
01/2017 - 03/2003
4ChitinasesIBA
01/2011 - 02/2008
3CytokinesIBA
10/2021 - 01/2019
3Amyloid (Amyloid Fibrils)IBA
10/2021 - 09/2016
3LipidsIBA
08/2021 - 01/2016
3CarnosineIBA
04/2021 - 08/2019
3Bevacizumab (Avastin)FDA Link
01/2021 - 01/2015
3Neuroprotective AgentsIBA
01/2021 - 11/2014
3Messenger RNA (mRNA)IBA
01/2020 - 07/2009
3Dopamine (Intropin)FDA LinkGeneric
01/2020 - 03/2012
3Peptides (Polypeptides)IBA
01/2019 - 09/2012
3SteroidsIBA
12/2018 - 03/2012
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2010 - 12/2003
3cloricromen (AD 6)IBA
08/2009 - 03/2003
3CoumarinsIBA
08/2009 - 03/2003
3alpha-chymotrypsinIBA
06/2007 - 12/2002
3Hyaluronic Acid (Hyaluronan)IBA
10/2006 - 04/2004
2Biological ProductsIBA
11/2021 - 12/2018
2Calcitriol (Calcijex)FDA LinkGeneric
09/2021 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021 - 01/2020
2Caffeine (No Doz)FDA LinkGeneric
01/2021 - 03/2008
2resolvin D1IBA
11/2020 - 01/2020
2Phospholipases A2 (Phospholipase A2)IBA
10/2020 - 12/2013
2TNF-Related Apoptosis-Inducing LigandIBA
10/2020 - 01/2019
2Ranibizumab (Lucentis)FDA Link
05/2020 - 01/2015
2Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 01/2017
2Dopamine D3 ReceptorsIBA
01/2020 - 01/2017
2CurcuminIBA
01/2019 - 01/2018
2Buspirone (Buspar)FDA LinkGeneric
01/2017 - 07/2014
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2015 - 07/2014
2HomocysteineIBA
01/2015 - 01/2014
2Carbon MonoxideIBA
05/2011 - 02/2010
2R- 1,1,1- trifluoro- 4- (5- fluoro- 2,3- dihydrobenzofuran- 7- yl)- 4- methyl- 2- (((2- methyl- 5- quinolyl)amino)methyl)pentan- 2- olIBA
03/2011 - 01/2011
2Morphine (MS Contin)FDA LinkGeneric
02/2010 - 03/2006
2Peroxidase (Myeloperoxidase)IBA
11/2008 - 04/2004
2FlunarizineIBA
04/2003 - 12/2002
2Arachidonic Acid (Vitamin F)IBA
09/2002 - 02/2002
1RNA (Ribonucleic Acid)IBA
11/2021
1Death Domain ReceptorsIBA
10/2021
1Paroxetine (Paxil)FDA LinkGeneric
05/2021
1DipeptidesIBA
04/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2021
1IonsIBA
04/2021

Therapy/Procedure

8Therapeutics
01/2022 - 05/2011
4Lasers (Laser)
01/2022 - 06/2015
3Vitrectomy
01/2022 - 11/2019
3Intravitreal Injections
01/2021 - 05/2015
3Injections
01/2021 - 01/2018
3Topical Administration
02/2020 - 01/2015
2Intraocular Injections
09/2017 - 12/2003